(Total Views: 399)
Posted On: 10/07/2020 11:23:39 AM
Post# of 145875
23LL and 23 placebo. That would be be a Closer to a 50% reduction based on the 2v1 trail. Why would placebo for any better when Leronlimab patients also getting SOC. We are safe and We give every person a way higher percentage of surviving. The numbers will show this.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)